A Study of the Association of Sleep Dysfunction and Burning Mouth Syndrome
NCT ID: NCT00862576
Last Updated: 2009-03-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
55 participants
OBSERVATIONAL
2006-06-30
2008-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Each case and control subject will be administered the following 4 questionnaires by interview: (1) enrollment questionnaire (2) Sleep scale from the medical outcomes study (MOS), (3) current sleep status scale and (4) a numerical rating scale for measurement of oral symptoms.
Cases (BMS patients) will be followed in the clinic or by telephone contact once per month for the following 6 months and questionnaires 1 (question 6 only), 2, 3 and 4 will be administered by interview.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Treatments on Pain and Quality of Life in Individual With Burning Mouth Syndrome
NCT06040190
Salivary Melatonin Levels and Sleep Quality in Patients With Burning Mouth Syndrome
NCT05309681
Efficacy of Melatonin in Burning Mouth Syndrome (BMS)
NCT02580734
Effect to the Photobiomodulation in the Burning Mouth Syndrome
NCT05871580
Burning Mouth Disorder (BMD) - A Neuropathic Pain Disorder
NCT00504387
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Burning Mouth Syndrome Group
No interventions assigned to this group
2
Control Group
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Controls will include patients with leukoplakia, pigmented lesions, traumatic lesions, aphthous ulcers, reticular oral lichen planus, benign tumors, mucoceles, and pemphigoid matched on age (5 years) and gender to the cases.
* New patients as well as those presenting for follow-up visits will be eligible.
Exclusion Criteria
* Pregnancy
* Systemic corticosteroid therapy within the previous 2 weeks.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, San Francisco
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University of California, San Francisco
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nita Chainani-Wu, DMD, MS, PhD
Role: PRINCIPAL_INVESTIGATOR
University of California, San Francisco
Sol Jr. Silverman, MA, DDS
Role: PRINCIPAL_INVESTIGATOR
University of California, San Francisco
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of California
San Francisco, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H1113-29221
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.